Laurus Generics Inc. is proud to offer Pirfenidone Tablets, USP 534 mg tablets, a prescription medication indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF). Laurus undertakes dedicated R&D in critical disease areas to develop medicines with a twin focus on quality and affordability.
Pirfenidone Tablets, USP 534 mg is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis (IPF). It is not known if Pirfenidone Tablets, USP 534 mg is safe and effective in children.
Please note: Pirfenidone does not reverse lung scarring or treat the symptoms of IPF. Its goal is to slow disease progression.
Did you know additional dosing options are available for your IPF therapy patients?
PIRFENIDONE is now available in 534 mg tablets, as well as standard 267 mg and 801 mg dosages, which can be ordered through your pharmacist.
Questions? Contact Laurus Customer Support at lauruslabsCS@icsconnect.com or call 833-3LAURUS.
| Product | Qty. | NDC | Cencora | Cardinal | McKesson |
|---|---|---|---|---|---|
| 534 mg | 90 Tablets | 42385-925-90 | 10272313 | 5809926 | 2643641 |
| Also available: | |||||
| 801 mg | 90 Tablets | 42385-926-90 | 10271509 | 5808324 | 2643658 |
| 267 mg | 3 bottles of 90 Tablets each | 42385-924-99 | 10271426 | 5808498 | 2643633 |
Idiopathic Pulmonary Fibrosis (IPF) is a specific type of interstitial lung disease (ILD), or diseases that cause inflammation and scarring of the lungs
Means the cause is unknown. IPF develops without any clear reason.
Refers to the lungs. IPF specifically affects the lung tissue.
Denotes scarring. Once there is scarring in the lungs, it cannot be reversed .
IPF is progressive, unpredictable, and irreversible. Early diagnosis and appropriate treatment are crucial.
This is not a complete list of all possible side effects. Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088 (1-800-332-1088) or www.fda.gov/medwatch or to Laurus Generics Inc. at 1-833-3-LAURUS (1-833-352-8787). Please see full Prescribing Information , including Patient Information, for additional important safety information.
US-PIRF-TABS-25-002